Bovine live attenuated LSDV-Neethling strain vaccine against Lumpy Skin Disease
To protect cattle when it matters most
According to the recommendations of WOAH and the Food and Agriculture Organization of the United Nations (FAO), homologous vaccines based on the Neethling strain provide more effective prevention of LSD compared to vaccines based on sheeppox virus strains.
These vaccines have been in use for over 60 years, and to date, there have been no reports of vaccine virus regaining virulence in vaccinated herds.
Mass vaccination of cattle against LSD with live vaccines based on the Neethling strain is considered the most effective control measure in the EU and most countries in Asia and Africa, including from an economic standpoint.
One dose of BOVIMUN LSD vaccine (1 ml) contains Lumpy Skin Disease virus, Neethling strain > 103.8 TCID50. This vaccine has higher antigen activity than the main competing vaccines that have a single immunizing dose (2 ml) containing > 103.5 TCID50.
This is the result of modern high-performance technologies for the purification and concentration of viruses used in BIOTESTLAB
BIOTESTLAB production processes comply with GMP requirements.
Since its launch in 2020, BOVIMUN LSD has been used in livestock production in Kazakhstan and Azerbaijan, where the vaccine has been shown to be highly effective in preventing Lumpy Skin Disease.
BOVIMUN LSD stimulates the formation of immunity 10 days after a single vaccination. Active immunity occurs on the 21st day after immunization. Duration of immunity up to 2 years.
BOVIMUN LSD is formulated to ensure the safety of pregnant cows. This means farmers can administer the vaccine at any time of year. Milk from vaccinated cows is used without restrictions. Calves from vaccinated cows are vaccinated at the age of 4-6 months; calves from unvaccinated cows are vaccinated at any age.
BOVIMUN LSD is a lyophilized preparation of chemically altered LSDV-Neethling strain, plus a solvent. The liquid solvent is used to rehydrate the lyophilized component
When vaccination is part of your control disease strategy, trust Bovimun LSD
What you need to know about Lumpy Skin Disease
Get access to more products to help you prevent bovine diseases, giving control of their herd’s health now and in the future
Combined vaccine against
Bovine Respiratory Disease Complex
(IBR, BVD, BRSV, PI-3)
Inactivated polyvalent vaccine
against Mastitis of cows
(Str. agalactiae, Str. uberis, S. aureus, E. coli)
Please, fill out a form, if you have any questions about ordering BOVIMUN LSD or if you have to become a distributor of BOVIMUN vaccines
With care for animal and human health
BIOTESTLAB, the creator of the Bovimun vaccines line, is a European company that has been specializing in the development, production, and marketing of vaccines, medicines, and disinfectants for use in veterinary.
BIOTESTLAB offers a wide portfolio of innovative high-quality products, including means for the prevention, treatment, and control of diseases in all major species of poultry, farm, and companion animals.
With our own latest scientific and laboratory complex and modern production facilities that meet the requirements of GMP, we successfully market our products in more than 20 countries.
By consistently providing the highest standards of quality, professionalism, and responsibility our goal is to become a trusted partner for veterinarians, producers, and animal owners.